The mitotic kinase Aurora-A and its partner protein TPX2 (Targeting Protein for Xenopus kinesin-like protein 2) are overexpressed in cancers, and it has been proposed that they work together as an oncogenic holoenzyme. TPX2 is responsible for activating Aurora-A during mitosis, ensuring proper cell division. Disruption of the interface with TPX2 is therefore a potential target for novel anticancer drugs that exploit the increased sensitivity of cancer cells to mitotic stress. Here, we investigate the interface using coprecipitation assays and isothermal titration calorimetry to quantify the energetic contribution of individual residues of TPX2. Residues Tyr8, Tyr10, Phe16, and Trp34 of TPX2 are shown to be crucial for robust complex formation, suggesting that the interaction could be abrogated through blocking any of the three pockets on Aurora-A that complement these residues. Phosphorylation of Aurora-A on Thr288 is also necessary for high-affinity binding, and here we identify arginine residues that communicate the phosphorylation of Thr288 to the TPX2 binding site. With these findings in mind, we conducted a high-throughput X-ray crystallography-based screen of 1255 fragments against Aurora-A and identified 59 hits. Over three-quarters of these hits bound to the pockets described above, both validating our identification of hotspots and demonstrating the druggability of this protein-protein interaction. Our study exemplifies the potential of high-throughput crystallography facilities such as XChem to aid drug discovery. These results will accelerate the development of chemical inhibitors of the Aurora-A/TPX2 interaction.

• MeSH
• aurora kinasa A chemie   metabolismus   MeSH
• jaderné proteiny chemie   metabolismus   MeSH
• krystalografie rentgenová MeSH
• lidé MeSH
• ligandy MeSH
• mapy interakcí proteinů účinky léků   MeSH
• objevování léků MeSH
• proteiny asociované s mikrotubuly chemie   metabolismus   MeSH
• proteiny buněčného cyklu chemie   metabolismus   MeSH
• simulace molekulového dockingu MeSH
• thiazolidiny chemie   farmakologie   MeSH
• vazba proteinů účinky léků   MeSH
• vazebná místa účinky léků   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• aurora kinasa A MeSH
• jaderné proteiny MeSH
• ligandy MeSH
• proteiny asociované s mikrotubuly MeSH
• proteiny buněčného cyklu MeSH
• thiazolidiny MeSH
• TPX2 protein, human MeSH Prohlížeč